Gingival crevicular fluid and serum levels of APRIL, BAFF and TNF-alpha in rheumatoid arthritis and osteoporosis patients with periodontal disease

Mackler, 1977, Immunoglobulin bearing lymphocytes and plasma cells in human periodontal disease, Journal of Periodontal Research, 12, 37, 10.1111/j.1600-0765.1977.tb00107.x Seymour, 1979, The phenotypic characterization of lymphocyte subpopulations in established human periodontal disease, Journal of Periodontal Research, 14, 39, 10.1111/j.1600-0765.1979.tb00216.x Seymour, 1979, Conversion of a stable T-cell lesion to a progressive B-cell lesion in the pathogenesis of chronic inflammatory periodontal disease: an hypothesis, Journal of Clinical Periodontology, 6, 267, 10.1111/j.1600-051X.1979.tb01930.x Hadj-Kacem, 2009, Autoimmune thyroid diseases: genetic susceptibility of thyroid-specific genes and thyroid autoantigens contributions, International Journal of Immunogenetics, 36, 85, 10.1111/j.1744-313X.2009.00830.x Mackay, 2007, B cells and the BAFF/APRIL axis: fast-forward on autoimmunity and signaling, Current Opinion in Immunology, 19, 327, 10.1016/j.coi.2007.04.008 Pers, 2008, Anti-TNF-alpha immunotherapy is associated with increased gingival inflammation without clinical attachment loss in subjects with rheumatoid arthritis, Journal of Periodontology, 79, 1645, 10.1902/jop.2008.070616 Yavuzyılmaz, 1992, Clinical and immunological characteristics of patients with rheumatoid arthritis and periodontal disease, Journal of Nihon University School of Dentistry, 34, 89, 10.2334/josnusd1959.34.89 Mercado, 2000, Is there a relationship between rheumatoid arthritis and periodontal disease?, Journal of Clinical Periodontology, 27, 267, 10.1034/j.1600-051x.2000.027004267.x Mercado, 2001, Relationship between rheumatoid arthritis and periodontitis, Journal of Periodontology, 72, 779, 10.1902/jop.2001.72.6.779 Yavuzyılmaz, 1992, Clinical and immunological characteristics of patients with rheumatoid arthritis and periodontal disease, The Journal of Nihon University School of Dentistry, 34, 89, 10.2334/josnusd1959.34.89 Löfman, 2000, Bone mineral density in diagnosis of osteoporosis: reference population, definition of peak bone mass, and measured site determine prevalence, Journal of Clinical Densitometry, 3, 177, 10.1385/JCD:3:2:177 Suda, 1999, Modulation of osteoclast differentiation and function by the new members of the tumour necrosis factor receptor and ligand families, Endocrine Reviews, 20, 345, 10.1210/edrv.20.3.0367 Yasuda, 1998, Osteoclast differentiation factor is a ligand for osteoprotegerin/osteoclast inhibitory factor and is identical to TRANCE/RANKL, Proceedings of the National Academy of Sciences of the United States of America, 95, 3597, 10.1073/pnas.95.7.3597 Quinn, 2000, Fibroblastic stromal cells express receptor activator of NF-kappa B ligand and support osteoclast differentiation, Journal of Bone and Mineral Research;, 15, 1459, 10.1359/jbmr.2000.15.8.1459 Horwood, 1999, Activated T lymphoctes support osteoclast formation in vitro, Biochemical and Biophysical Research Communications, 265, 144, 10.1006/bbrc.1999.1623 Lacey, 1998, Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation, Cell, 93, 165, 10.1016/S0092-8674(00)81569-X Kong, 1999, OPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymph-node organogenesis, Nature, 397, 315, 10.1038/16852 Gümüş, 2013, Gingival crevicular fluid, serum levels of receptor activator of nuclear factor-kappa B ligand, osteoprotegerin, interleukin-17 in rheumatoid arthritis and osteoporosis patients with periodontal disease, Journal of Periodontology, 10.1902/jop.2013.120595 Le Pottier, 2009, New ELISA for B cell-activating factor, Clinical Chemistry, 55, 1843, 10.1373/clinchem.2009.129940 Boström, 1999, Smoking and crevicular fluid levels of IL-6 and TNF-α in periodontal disease, Journal of Clinical Periodontology, 26, 352, 10.1034/j.1600-051X.1999.260604.x Howells, 1995, Cytokine networks in destructive periodontal disease, Oral Diseases, 1, 266, 10.1111/j.1601-0825.1995.tb00192.x Tervahartiala, 2001, Tumor necrosis factor-alpha and its receptors, p55 and p75, in gingiva of adult periodontitis, Journal of Dental Research, 80, 1535, 10.1177/00220345010800061101 Schneider, 1999, BAFF, a novel ligand of the tumor necrosis factor family, stimulates B cell growth, Journal of Experimental Medicine, 189, 1747, 10.1084/jem.189.11.1747 Roschke, 2002, BLyS and APRIL form biologically active heterotrimers that are expressed in patients with systemic immune-based rheumatic diseases, Journal of Immunology, 169, 4314, 10.4049/jimmunol.169.8.4314 Daridon, 2008, BAFF, APRIL, TWE-PRIL: who's who?, Autoimmunity Reviews, 7, 267, 10.1016/j.autrev.2007.05.002 Bannish, 2001, Ligand-independent signaling functions for the B lymphocyte antigen receptor and their role in positive selection during B lymphopoiesis, Journal of Experimental Medicine, 194, 1583, 10.1084/jem.194.11.1583 Gerondakis, 2003, The role of Rel/NF-κB transcription factors in B lymphocyte survival, Seminars in Immunology, 15, 159, 10.1016/S1044-5323(03)00036-8 Claudio, 2002, BAFF-induced NEMO-independent processing of NF-κB2 in maturing B cells, Nature Immunology, 3, 958, 10.1038/ni842 Senftleben, 2001, Activation by IKKα of a second, evolutionary conserved, NF-κB signaling pathway, Science, 293, 1495, 10.1126/science.1062677 Khan, 2009, B Cell Receptor and BAFF receptor signaling regulation of B cell homeostasis, Journal of Immunology, 183, 3561, 10.4049/jimmunol.0800933 Yu, 2000, APRIL and TALL-I and receptors BCMA and TACI: system for regulating humoral immunity, Nature Immunology, 1, 252, 10.1038/79802 Pers, 2005, Is periodontal disease mediated by salivary BAFF in Sjogren's syndrome?, Arthritis & Rheumatism, 52, 2411, 10.1002/art.21205 Onal, 2012, Receptor activator of nuclear factor κB ligand (RANKL) protein expression by B lymphocytes contributes to ovariectomy-induced bone loss, Journal of Biological Chemistry, 287, 29851, 10.1074/jbc.M112.377945 Kikuta, 2013, Dynamic visualization of RANKL and Th17-mediated osteoclast function, Journal of Clinical Investigation, 10.1172/JCI65054 Lappin, 1999, Relative proportions of mononuclear cell types in periodontal lesions analyzed by immunohistochemistry, Journal of Clinical Periodontology, 26, 183, 10.1034/j.1600-051X.1999.260309.x Tew, 1989, Polyclonal B-cell activation in periodontitis, Journal of Periodontal Research, 24, 225, 10.1111/j.1600-0765.1989.tb01787.x Li, 2007, B cells and T cells are critical for the preservation of bone homeostasis and attainment of peak bone mass in vivo, Blood, 109, 3839, 10.1182/blood-2006-07-037994 Khosla, 2001, The OPG/RANKL/RANK system, Endocrinology, 142, 5050, 10.1210/endo.142.12.8536 Hemingway, 2011, RANKL-independent human osteoclast formation with APRIL, BAFF, NGF, IGF I and IGF II, Bone, 48, 938, 10.1016/j.bone.2010.12.023 Kotsovilis, 2010, Syndecan-1 immunohistochemical expression in gingival tissues of chronic periodontitis patients correlated with various putative factors, Journal of Periodontal Research, 45, 520